Dow Up 0.48% Nasdaq Up 0.43%

Northwest Biotherapeutics, Inc. (NWBO)

-NasdaqCM
6.38 0.20(3.04%) Aug 19, 4:00PM EDT
Prev Close:6.58
Open:6.65
Bid:6.30 x 20100
Ask:6.38 x 1000
1y Target Est:5.00
Beta:2.98
Next Earnings Date:N/A
Day's Range:6.32 - 6.65
52wk Range:3.10 - 10.64
Volume:464,180
Avg Vol (3m):1,059,110
Market Cap:379.64M
P/E (ttm):N/A
EPS (ttm):-2.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NWBO

Comparison

Symbol% ChgMkt Cap
NWBODown 3.04%379.64M
AGEN206.21M
DNDN209.83M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):978.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Northwest Biotherapeutics, Inc., a development stage biotechnology company, discovers and develops immunotherapy products to treat cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback